Unbiased AI-powered news
18 stories related to this topic, newest first.
newatlas.comA systematic review of five trials presented at ENDO 2026 found GLP-1 medications did not lower male reproductive hormones. Some studies reported improvements in testosterone and sperm parameters among obese men.
Fox NewsNew research presented at a medical conference found adults using GLP-1 medications for weight loss decreased physical activity levels. Average daily steps fell and moderate-to-vigorous exercise minutes declined after starting treatment.
Fox NewsNinety adults who lost 8% body weight regained 2.6 pounds on average with the bacterium versus 7.1 pounds on placebo over 24 weeks.
ncbi.nlm.nih.govA new randomized trial published in JAMA assessed whether weight loss reduces atrial fibrillation recurrence. Results differed based on whether the condition was chronic or recent in onset.
nypost.comJack Osbourne posted a video on Instagram addressing online comments about his weight. He said he has maintained the same weight since finishing a reality show six months ago.
forbes.comTwo randomized studies published in Nature Medicine show patients who switched from tirzepatide or semaglutide to daily oral orforglipron maintained 75 to 79 percent of their weight loss after one year, compared with 38 to 49 percent for those on placebo. The trial involved 376 p…
cnet.comResearch published in the International Journal of Environmental Research and Public Health and presented at the European Obesity Conference analyzed 18 prior studies. Participants maintained roughly 1% of weight loss for every additional 1,000 steps walked daily over 1.5 years.…
New York PostA review of studies presented at the European Congress on Obesity found that increasing to about 8,500 steps per day during and after weight loss programs helped participants sustain most of their weight reduction. The 10,000-step target originated as a 1960s Japanese pedometer m…
EuronewsA new analysis of 14 clinical trials shows that participants who increased their daily steps to around 8,500 during weight loss and maintenance phases sustained an average 3.28 percent reduction in body weight. The research, involving nearly 4,000 overweight or obese adults, was…
automotiveworld.comResearchers reviewed 14 studies involving 3758 overweight or obese adults and found that increasing daily steps to around 8500 during and after weight loss helped maintain results. The analysis showed participants on lifestyle programs sustained most of their weight loss over 10.…
channelnewsasia.comPhysicians at longevity clinics have observed increased interest in injectable peptides for weight loss and anti-aging. They report cases of adverse effects including allergic reactions and hormone disturbances from unauthorized use. Discussions with seven doctors highlight conce…
thehollywoodgossip.comCountry singer Jelly Roll revealed he gained 12 pounds following a collarbone injury that prevented exercise. He discussed setbacks in his health journey, from 540 pounds to 265 pounds earlier in 2026. New goals include training for the New York City Marathon and aiming for a shi…
Substrate placeholder — needs reviewHers is a telehealth platform offering treatments for weight loss, hair loss and mental health. The services include GLP-1 medications, hair loss kits and mental health support. This article examines the costs and details of these offerings based on reporting from nypost.com.
thehindu.comEli Lilly and Novo Nordisk have introduced oral versions of their GLP-1 receptor agonist drugs for weight management. These pills provide an alternative to weekly injections, with clinical data showing they help maintain weight loss. Side effects and costs remain similar to the i…
Substrate placeholder — needs reviewIndividuals who lose significant weight, often using GLP-1 medications, frequently experience excess loose skin that may require surgical removal. Cases like Samantha Milton, who lost 260 pounds and underwent five procedures to address 12 pounds of excess skin, highlight the phys…
Substrate placeholder — needs reviewResearch indicates that GLP-1 receptor agonists such as Ozempic and Wegovy may double the risk of divorce, similar to patterns observed in bariatric surgery patients. Professor Per-Arne Svensson from Sweden's Institute of Health and Care Sciences has studied the connection betwee…
Substrate placeholder — needs reviewEquity research firm Bernstein estimates that GLP-1 drugs, used by millions for weight loss, could drive up to $13 billion in additional annual spending at apparel retailers. Users of these medications are purchasing new clothing to fit their changed body sizes. The projection hi…
Substrate placeholder — needs reviewTens of millions of Americans are using GLP-1 drugs that lead to rapid weight loss. This shift in body sizes is driving demand for new clothing. Retailers are adapting their inventories to meet the needs of these consumers.